Orgasm Inc Case Analysis
“have you ever been unsatisfied during sex” and “have you ever been unable to reach orgasm during sex”) as being …show more content…
The issue with the pharmaceutical company’s large extent of involvement in the creation and diagnosis of Female Sexual Disorder is that, as a benefactor in the event that the disorder was real due to their product’s inevitable popularity as a solution to it, is that they had no possible way to claim objectivity. If the pharmaceutical company controls all the studies attempting to legitimize the disorder, they are likely to skew the results or settle for less stringently controlled tests to ensure their product is necessary and purchased by as many consumers as possible. Their goal is not the health of women, but to make money by marketing their drug.
There are several reasons that led Liz Canner to (correctly) believe that the pharmaceutical company was fabricating the extent, if not the entire existence, of the Female
Sexual Dysfunction disorder. While interviewing members of various parts of the company, she found many members at a loss to explain how exactly Female Sexual Dysfunction differed …show more content…
When she emailed the company to inquire why they still promoted the drug so strongly with ambiguous results, she received no answer. This revealed to her that the company’s focus was not the health of the customers, but rather to sell it to as many women as possible, preying on the misconception that their experiences of sexual dissatisfaction were abnormal. The national effect of the results of the singular faulty study that claimed that 50% of women experienced Female Sexual Disorder demonstrates that the disease was in fact socially constructed. Once the “facts” about the disorder were exposed to the public, a huge market opened for women who now believed that what would previously be considered normal intimacy issues was a sign of a medical issue. This social atmosphere caused women to turn in droves to any solution that they could find. She further revealed that this mentality is not limited to that drug industry, but extends to other practices. Sadly, Female Sexual Disorder is not the only
example of such a phenomenon, in which a campaign by a practice benefitting from